# Dapsone

NDC: 33342-534
Generic name: Dapsone
Labeler / Manufacturer: Macleods Pharmaceuticals Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20260708

FDA application: ANDA218335

## Active ingredients

- DAPSONE: 25 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"33342-534"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=33342-534
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=839d7440-ba0e-4c56-b648-d374b155cf03